Lea Darrell Shane has filed 3 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 260000 shares of Cellectar Biosciences, Inc. ($CLRB) on June 14, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 14, 2024 | Cellectar Biosciences, Inc. | $CLRB | Lea Darrell Shane | Chief Commercial Officer | A | Stock option (right to buy) | 260000 | $0.00 | 260,000.0000 | 29,346,679 | 9999.99% | 0.89% |
| Dec. 8, 2023 | Cellectar Biosciences, Inc. | $CLRB | Lea Darrell Shane | Chief Commercial Officer | A | Common Stock | 39599 | $0.00 | 39,599.0000 | 11,308,738 | 9999.99% | 0.35% |
| June 23, 2023 | Cellectar Biosciences, Inc. | $CLRB | Lea Darrell Shane | Chief Commercial Officer | A | Stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 11,261,217 | 9999.99% | 0.89% |